Evaluation of immune-related response criteria (irRC) in patients (pts) with advanced melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475 Meeting Abstract


Authors: Hodi, F. S.; Ribes, A.; Daud, A.; Hamid, O.; Robert, C.; Kefford, R.; Hwu, W. J.; Gangadhar, T. C.; Joshua, A. M.; Hersey, P.; Weber, J. S.; Dronca, R. S.; Perrone, A. M.; Gammage, L.; Mille, D.; Xue, D. H.; Kang, S. P.; Chun, P.; Ebbinghaus, S.; Wolchok, J. D.
Abstract Title: Evaluation of immune-related response criteria (irRC) in patients (pts) with advanced melanoma (MEL) treated with the anti-PD-1 monoclonal antibody MK-3475
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613202898
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.3006
Notes: Meeting Abstract: 3006^ -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok